Nashville, TN, United States of America

Clayton Kaiser

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Helios Cardio Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clayton Kaiser: Innovator in Therapeutic Delivery Systems

Introduction

Clayton Kaiser is an accomplished inventor based in Nashville, TN (US). He has made significant contributions to the field of medical technology, particularly in the area of therapeutic delivery systems. His innovative approach focuses on improving the delivery of therapeutic compositions to the heart, which can have profound implications for patient care.

Latest Patents

Kaiser holds a patent for a therapeutic composition delivery device. This patent describes methods, compositions of matter, and devices for delivering a therapeutic composition to the heart of a subject using a biopolymer scaffold material. In some embodiments, the biopolymer scaffold material, which includes the therapeutic composition, may be attached to a first cardiac tissue of a subject. The therapeutic composition is effectively delivered from the biopolymer scaffold material to the heart of the subject.

Career Highlights

Kaiser is currently associated with Helios Cardio Inc., where he continues to develop innovative solutions in cardiac care. His work is characterized by a commitment to enhancing the efficacy of therapeutic interventions for heart-related conditions.

Collaborations

Kaiser collaborates with notable professionals in the field, including Kevin Cornwell and Yiannis Monovoukas. Their combined expertise contributes to the advancement of technologies that aim to improve patient outcomes in cardiac health.

Conclusion

Clayton Kaiser exemplifies the spirit of innovation in the medical technology sector. His work on therapeutic delivery systems showcases the potential for advancements that can significantly benefit patients with heart conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…